You are viewing an expired study
This study is not currently recruiting Study Participants on If you would like to find active studies please search for clinical trials

Philadelphia, Pennsylvania

  • Failure to Thrive


This clinical trial will compare the mean first year height velocity of somatropin-treated prepubertal patients with SHOX deficiency with the height velocity of a control group of untreated prepubertal patients with SHOX deficiency. Both groups will be compared to a somatropin-treated group of girls with Turner syndrome. After the second year patients in the control group have the option to receive treatment as well. All patients will optionally be treated until they achieved adult height.


Inclusion Criteria: - Turner Syndrome or SHOX disorder - SHOX: bone age greater than 10 years for boys, greater than 8 years for girls, Turner: bone age greater than 9 years - Height below 3rd percentile or height below 10th percentile and growth velocity below 25th percentile - Prepubertal: For girls, Tanner stage 1, for boys Tanner stage 1 and testicular volume no more than 2 mL Exclusion Criteria: - GH deficiency or known insensitivity - Evidence of tumor activity - Diabetes mellitus or history of impaired glucose tolerance - Any severe illness known to interfere growth



Primary Contact:

Study Chair
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company

Backup Contact:


Location Contact:

Philadelphia, Pennsylvania
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.